This study was carried to examine the effectiveness of using chest computed tomography (CT) for the screening of osteoporosis (OP) and predicting the risk of fractures (bone breaks) in patients with breast cancer (BC). The authors found that CT can be used for predicting OP and determining the risk of fractures in these patients. 

This study was carried out to look at the risk of developing a second cancer in patients with breast cancer (BC) undergoing statin therapy. The authors found that there was little association between statin use and second cancer risk in these patients.

This study examined how COVID-19 infection affects patients with cancer undergoing chemotherapy and the role of other factors in COVID-19 complications. The results showed that patients with advanced age and other medical conditions had a higher risk of COVID-19 complications but chemotherapy treatment did not need to be stopped.

This study looked at treating patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer and brain metastases (BM) with tucatinib (Tukysa) plus trastuzumab (Herceptin) and capecitabine (Xeloda). This study found that this treatment reduces the risk of cancer worsening in these patients. 

This study wanted to find out if taking pictures of lymph nodes using medical imaging techniques helped in finding out if treatment for lymph node swelling was working. The study found that using lymphoscintigraphy helped in evaluating the treatment of lymph node swelling. 

This study examined if patients with breast cancer that took different vitamin supplements before or during chemotherapy had poorer results from treatment. The results showed that anti-oxidants vitamin A, C, E, carotenoids and coenzyme Q10, as well as vitamin B12 and iron, negatively impact the outcomes of patients.

This study examined the effects of granulocyte colony-stimulating factor (G-CSF) given as a preventative measure in patients with high- and medium-risk cancer receiving chemotherapy. The results showed that preventative G-CSF allowed more patients to complete chemotherapy treatment and lowered patients’ chances of developing secondary tumors.

This study examined if acupuncture is an effective treatment for patients with nerve damage caused by chemotherapy for breast cancer. The results showed that patients had improved sensory and muscle symptoms, less pain, and improved quality of life following acupuncture treatment.

This study evaluated whether melatonin could improve the side effects of chemotherapy for women with breast cancer. It found that melatonin improved sleep, depression symptoms, and clear thinking during chemotherapy.

This study looked at whether pertuzumab (Perjeta) benefits patients with metastatic HER2-positive breast cancer when added to trastuzumab (Herceptin) and docetaxel (Taxotere) treatment. They found that adding pertuzumab improved long-term patient outcomes.